Ajanta Pharma promoter reduces share pledge, signaling positive development

Ravi Agrawal, a promoter of Ajanta Pharma Limited and trustee of Ravi Agrawal Trust, announced on November 12, 2025, the release of a pledge on 1,050,000 equity shares of the company. This action was attributed to "Excess Pledge" and disclosed under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Before this release, Ravi P Agrawal, trustee Ravi Agrawal Trust, held 13.00% of the total share capital, with 5.69% (7,113,920 shares) previously encumbered. The released pledge represents 0.84% of the total share capital, reducing the encumbered shares for this entity to 6,063,920, or 4.85% of the total share capital. The pledge was originally for business financing.

This disclosure was made to both the BSE Limited and the National Stock Exchange of India.